Brigitte Sallee, MD
Dermatology · Oklahoma City, OKNPI 1699124768
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $6,339 of the $7,897 with a category attached, or 80.3%. It is spread thinly across 25 manufacturers, the largest accounting for just 22.2% — the pattern of someone who eats at a lot of different presentations.
Across 186 payments — averaging $42.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Pfizer$2K
- Lumenis BE Inc$1K
- Dermavant Sciences, Inc.$675
- Johnson & Johnson$592
- AbbVie$491
- Lilly USA, LLC$426
- plus $3K from 19 others
What the payments were for
- Travel & lodging$1,43318%
- Food & beverage$6,33980%
- Education$1252%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Pfizer | 7 | $1,750 |
| Lumenis BE Inc | 1 | $1,097 |
| Dermavant Sciences, Inc. | 16 | $675 |
| Johnson & Johnson | 21 | $592 |
| AbbVie | 20 | $491 |
| Lilly USA, LLC | 20 | $426 |
| UCB, Inc. | 10 | $367 |
| Regeneron Healthcare Solutions, Inc. | 10 | $335 |
| Arcutis Biotherapeutics, Inc. | 8 | $270 |
| Amgen | 7 | $203 |
| Botanix SB Inc | 7 | $194 |
| Galderma Laboratories, L.p. | 6 | $191 |
| Sun Pharmaceutical Industries Inc. | 8 | $186 |
| Novartis | 7 | $174 |
| Incyte Corporation | 8 | $161 |
| Sanofi | 7 | $158 |
| Dermira, Inc. | 1 | $122 |
| Mayne Pharma Commercial LLC | 4 | $102 |
| LEO Pharma Inc. | 4 | $94 |
| E.r. Squibb & Sons, L.L.C. | 6 | $93 |
| Convatec Inc. | 1 | $63 |
| Shield Therapeutics Inc | 2 | $48 |
| Boehringer Ingelheim | 2 | $47 |
| Kerecis Limited | 2 | $40 |
| Almirall LLC | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$7,897 in reported general payments places this provider in the 70th percentile of 114 dermatology providers in Oklahoma.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clobetasol Propionate | 52 | $1,293 |
| Ketoconazole | 98 | $1,218 |
| Doxycycline Monohydrate | 47 | $898 |
| Clindamycin Phosphate | 24 | $687 |
| Fluocinonide | 23 | $684 |
| Ammonium Lactate | 27 | $650 |
| Hydroxychloroquine Sulfate | 11 | $620 |
| Tretinoin | 16 | $481 |
| Triamcinolone Acetonide | 69 | $475 |
| Cephalexin | 108 | $384 |
| ValacyclovirValacyclovir Hcl | 14 | $265 |
| Mupirocin | 31 | $186 |
| Terbinafine Hcl | 19 | $175 |
| Minoxidil | 23 | $171 |
| Hydrocortisone | 33 | $139 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Oklahoma City
- Yaohan LamOklahoma City$88K
- Kimberly JerdanOklahoma City$59K
- Mark DawkinsOklahoma City$56K
- Quy PhamOklahoma City$14K
- Sunita CrittendenOklahoma City$13K
- Tiffany BrazealOklahoma City$13K
- Robert LehrOklahoma City$11K
- Courtney CookOklahoma City$10K
- Clifford HendersonOklahoma City$9K
- Roy RindlerOklahoma City$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.